MNOV vs ENTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENTX Captures Institutional Edge (3โ1 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MNOV counters with relative strength in Valuation. Fundamentally, MNOV trades at 8.5x Forward P/E with -1232.2% operating margin (+12.4% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, MNOV sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MNOV Revenue | ENTX Revenue | MNOV Op. Margin | ENTX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2012 | $0M | N/A | -1363.8% | N/A | MNOV |
| FY2020 | N/A | $0M | N/A | -3059.7% | ENTX |
| FY2021 | $0M | $0M | -253.0% | -2139.6% | MNOV |
| FY2022 | N/A | $0M | N/A | -9714.2% | ENTX |
| FY2023 | $0M | N/A | -990.0% | N/A | MNOV |
| FY2024 | N/A | $0M | N/A | -5295.6% | ENTX |
| FY2025 | $0M | $0M | -3242.5% | -27450.0% | MNOV |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MNOV | ENTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $65.1M | $571.2M | Larger Scale | ENTX |
| Trailing P/E Ratio Valuation | 8.5x | N/M | Lower Multiple | MNOV |
| Forward P/E Ratio Valuation | 8.5x | N/M | Lower Multiple | MNOV |
| Revenue Growth (YoY) Growth | +12.4% | -100.0% | Higher Growth | MNOV |
| Operating Margin (TTM) Profitability | -1232.2% | 0.0% | Higher Margin | ENTX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -24.8% | -20.3% | Higher ROE | ENTX |
| 52-Week Range Position Momentum | 3% ($1โ$4) | 73% ($1โ$4) | Stronger Trend | ENTX |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 38% Vol | 0.92ฮฒ ยท 53% Vol | Lower Realized Risk | MNOV |
| Unified Institutional Score Composite Signal | 50.2 / 100 (HOLD) | 47.5 / 100 (HOLD) | Higher Composite | MNOV |